Post by Incyte on X
Incyte@Incyte
XToday at the American Society of Clinical Oncology® (@ASCO) Annual Meeting we shared new data from the pivotal frontMIND trial in patients with previously untreated, high-risk diffuse large B-cell lymphoma (DLBCL), simultaneously published in @TheLancet. Learn more. #ASCO26
4 likes0 repliesPosted May 30, 2026